It's the third most-common cancer in the USA, and the leading cause of cancer deaths—and doesn't only affect whom you might ...

A nurse-led intervention had a greater effect on dyspnea among patients with advanced lung cancer who experienced improvement in their psychological distress.

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...